Prism Medico & Pharmacy Stock Screener | Share Price & Fundamental Analysis
PRISMMEDI
NBFC
Screen Prism Medico & Pharmacy share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹19.61
▲
0.47 (2.46%)
Market Cap
₹11.84 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.77
EPS (TTM)
₹0.07
Dividend Yield
-
Debt to Equity
0.17
52W High
₹24.51
52W Low
₹11.72
Operating Margin
-
Profit Margin
-
Revenue (TTM)
₹10.00
EBITDA
-
Net Income
-
Total Assets
₹21.00
Total Equity
₹13.00
Prism Medico & Pharmacy Share Price History - Stock Screener Chart
Screen PRISMMEDI historical share price movements with interactive charts. Analyze price trends and patterns.
Prism Medico & Pharmacy Company Profile - Fundamental Screener
Screen Prism Medico & Pharmacy company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PRISMMEDI shares.
Sector
Financial Services
Industry
NBFC
Sub-Sector
NBFC
Segment
E
ISIN
INE730E01016
Prism Medico & Pharmacy Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PRISMMEDI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2019 | 2018 | 2017 |
|---|---|---|---|
| Assets | |||
| Total Assets | 21 | 16 | 17 |
| Current Assets | 11 | 4 | 7 |
| Fixed Assets | 9 | 9 | 10 |
| Liabilities | |||
| Total Liabilities | 21 | 16 | 17 |
| Current Liabilities | 0 | 0 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 13 | 13 | 13 |
| Share Capital | 6 | 6 | 6 |
| Reserves & Surplus | 7 | 7 | 7 |
Screen PRISMMEDI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2019-Dec | 2019-Sept | 2019-Jun | 2019-Mar | 2018-Dec | 2018-Sept | 2018-Jun | 2018-Mar | 2017-Dec | 2017-Sept | 2017-Jun | 2017-Mar | 2016-Jun | 2016-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 7 | 9 | 17 | 17 | 15 | 6 | 0 | 5 | 6 | 12 | 3 | 0 | 0 |
| Expenses | 10 | 6 | 9 | 17 | 17 | 15 | 5 | 1 | 5 | 6 | 11 | 2 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | -1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Operating Profit % | 0.00% | 3.00% | 2.00% | -5.00% | 1.00% | 2.00% | 7.00% | -50.00% | 1.00% | 1.00% | 7.00% | 26.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| EPS | -0.07 | 0.15 | 0.21 | -1.21 | 0.24 | 0.46 | 0.62 | -0.70 | -0.19 | -0.23 | 1.12 | 0.90 | -0.53 | 0.00 |
Prism Medico & Pharmacy Cash Flow Screener - Liquidity Fundamentals
Screen PRISMMEDI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2019-March | 2018-March | 2017-March |
|---|---|---|---|
| Operating Activities | 0 | 4 | 0 |
| Investing Activities | 0 | -3 | 0 |
| Financing Activities | -1 | -2 | 0 |
| Net Cash Flow | -1 | -1 | 0 |
Screen PRISMMEDI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 23.93% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 65.26% | 65.26% | 66.07% | 67.23% | 67.30% | 65.77% | 65.36% | 61.78% |
| Other Holding | 9.74% | 9.74% | 8.93% | 7.77% | 7.70% | 9.23% | 9.64% | 14.29% |
| Shareholder Count | 4,315 | 4,306 | 4,302 | 3,792 | 3,866 | 4,107 | 4,178 | 3,558 |
Prism Medico & Pharmacy Dividend Screener - Share Yield Analysis
Screen PRISMMEDI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Prism Medico & Pharmacy Index Membership - Market Screener Classification
Screen PRISMMEDI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Prism Medico & Pharmacy Market Events Screener - Corporate Actions
Screen PRISMMEDI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -14.25% | ||
| Annual General Meeting | NA | 20.06% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.89% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.65% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 13.42% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.47% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.04% |
| 2018-05-30 | 2018-05-30 | Change Of Name | NA | 0.00% |
Prism Medico & Pharmacy Competitors Screener - Peer Comparison
Screen PRISMMEDI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Bajaj Finance | 627,102 | 33.78 | 69,725 | 26.81% | 16,780 | 46.59 |
| Jio Financial Services | 189,800 | 115.54 | 2,079 | 12.09% | 1,613 | 48.05 |
| Shriram Finance | 175,846 | 17.20 | 41,860 | 19.61% | 9,423 | 77.88 |
| Muthoot Finance | 152,173 | 21.02 | 20,325 | 34.04% | 5,352 | 59.57 |
| Cholamandalam Investment | 133,353 | 29.89 | 26,153 | 34.67% | 4,260 | 32.08 |
| SBI Cards | 82,994 | 43.21 | 18,637 | 6.60% | 1,916 | 51.02 |
| M&M Financial Services | 54,807 | 21.21 | 18,531 | 16.03% | 2,261 | 70.09 |
| Sundaram Finance | 54,615 | 27.83 | 8,563 | 17.53% | 1,813 | 62.46 |
| Authum Inv & Infr | 49,294 | 12.29 | 4,612 | 76.63% | 4,241 | 60.69 |
| Poonawalla Fincorp | 36,650 | 167.26 | 4,223 | 34.17% | -98 | 55.28 |
Prism Medico & Pharmacy Company Announcements - News Screener
Screen PRISMMEDI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-21 | Revised Outcome Of The Board Meeting Held On 14Th November 2025. | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-06 | Board Meeting Intimation for Intimation Of Board Meeting. | View |
| 2025-10-27 | Undertaking Of Functional Website. | View |
| 2025-10-17 | Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-01 | Compliance-57 (5) : intimation after the end of quarter | View |
| 2025-10-01 | Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-10-01 | Closure of Trading Window | View |
| 2025-09-30 | Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025. | View |
| 2025-09-30 | Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means. | View |
| 2025-09-12 | Revised Outcome Of Board Meeting Dated 14Th August 2025. | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Intimation Of Record Date. | View |
| 2025-09-05 | Intimation Of Book Closure. | View |
| 2025-09-05 | Notice Of 23Rd Annual General Meeting. | View |
| 2025-09-05 | Annual Report For The Financial Year 2024-2025. | View |
| 2025-09-05 | Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-09-01 | Board Meeting Intimation for Intimation Of Board Meeting. | View |